K
Keiko Katayose
Researcher at University of Miyazaki
Publications - 13
Citations - 406
Keiko Katayose is an academic researcher from University of Miyazaki. The author has contributed to research in topics: Bone marrow & Leukemia. The author has an hindex of 7, co-authored 12 publications receiving 387 citations.
Papers
More filters
Journal ArticleDOI
Development of ET, primary myelofibrosis and PV in mice expressing JAK2 V617F
Kotaro Shide,Haruko Shimoda,Takashi Kumano,Kennosuke Karube,Takuro Kameda,Katsuto Takenaka,Seido Oku,Hiroo Abe,Keiko Katayose,Youko Kubuki,Kazunori Kusumoto,Satoru Hasuike,Yoshihiro Tahara,Kenji Nagata,Tadashi Matsuda,Kouichi Ohshima,Mine Harada,Kazuya Shimoda +17 more
TL;DR: It is concluded that in vivo expression of JAK2 V617F results in ET-, PMF- and PV-like disease.
Journal ArticleDOI
TET2 is essential for survival and hematopoietic stem cell homeostasis.
Kotaro Shide,Takuro Kameda,Haruko Shimoda,Takumi Yamaji,Hiroo Abe,Ayako Kamiunten,Masaaki Sekine,Tomonori Hidaka,Keiko Katayose,Youko Kubuki,Shojiro Yamamoto,Tadashi Miike,Hisayoshi Iwakiri,Satoru Hasuike,Kenji Nagata,Kosuke Marutsuka,Atsushi Iwama,Tadashi Matsuda,Akira Kitanaka,Kazuya Shimoda +19 more
TL;DR: Data indicate that TET2 has a critical role in survival and HSC homeostasis, and TET1trap/trap HSCs exhibit an increased self-renewal ability in vivo.
Journal ArticleDOI
CD3 and EBER double positive cells in bone marrow are a diagnostic aid for EBV-positive T-cell lymphoproliferative disorders of childhood
Yuri Yamada,Ayako Kamiunten,Tomonori Hidaka,Masafumi Sekine,Kousuke Marutsuka,Keiko Katayose,Yoko Kubuki,Hisanori Iwakiri,Satoru Hasuike,Mai Tsuchimochi,Kenichi Nakamura,Shojirou Yamamoto,Yoshinori Otsubo,Norihisa Kusumoto,Toshiharu Eto,Kenji Nagata,Akira Kitanaka,Kazuya Shimoda +17 more
TL;DR: A case of Epstein–Barr virus-positive T-cell lymphoproliferative disorders (EBV+ T- cell LPD) of childhood with high fever, jaundice, hepatosplenomegaly, pancytopenia, and disseminated intravascular coagulation is described.
Journal ArticleDOI
Elevated HIF-1α expression of acute myelogenous leukemia stem cells in the endosteal hypoxic zone may be a cause of minimal residual disease in bone marrow after chemotherapy.
Takuya Matsunaga,Osamu Imataki,Eri Torii,Tomohiro Kameda,Kotaro Shide,Haruko Shimoda,Ayako Kamiunten,Masaaki Sekine,Yasuhiro Taniguchi,Shojiro Yamamoto,Tomonori Hidaka,Keiko Katayose,Youko Kubuki,Hiroaki Dobashi,Shuji Bandoh,Hiroaki Ohnishi,Fumio Fukai,Kazuya Shimoda +17 more
TL;DR: Expermental evidence suggests that the incorporation of LSCs in niches n the BM promotes the chemoresistance of AML, and this supports the hypothesis that MRD in the bone marrow is a principal mechanism for AML relapse.
Journal ArticleDOI
The impact of cytogenetic abnormalities on the prognosis of primary myelofibrosis: a prospective survey of 202 cases in Japan
Tomonori Hidaka,Kotaro Shide,Haruko Shimoda,Takurou Kameda,Keiko Toyama,Keiko Katayose,Youko Kubuki,Kenji Nagata,Katsuto Takenaka,Koichi Akashi,Takashi Okamura,Yoshiyuki Niho,Hideaki Mizoguchi,Mitsuhiro Omine,Keiya Ozawa,Mine Harada,Kazuya Shimoda +16 more
TL;DR: Although the presence of an abnormal karyotype did not affect the prognosis, primary myelofibrosis patients with cytogenetic abnormalities other than 13q− and 20q− showed an inferior prognosis compared to patients with a normal karyotypes or sole 13q– or 20q– abnormalities.